A man sits on the couch under a blanket while taking his temperature.


This study is examining the effectiveness of a medication at treating the rebound illness. Patients must have been diagnosed with COVID-19 and have completed a 5-day course of Paxlovid treatment and experienced symptom relief. Qualifying rebound symptoms must occur within 14 days of completion of Paxlovid course. This study has 10 visits over a 24-week period.

Qualified Participants are: 

  • Patients aged 12 years and older, who are suffering rebound symptoms from COVID-19 infection after being treated with Paxlovid.


4300 Clime Rd

Columbus, Ohio 43228

(614) 372-6857

COVID-19 Rebound Study - Columbus

WellNow Urgent Care & Research partners with multinational pharmaceuticals, biotechnology companies, medical device manufacturers & CROs to help drive improvements to health and well-being. In our 15 years of research, WellNow has had over 17,000 visits to our network of clinical research sites.
Facebook for wellnow research
Youtube for WN research
Twitter for WN Research